查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1671179

全球老年药物市场、规模、占有率、趋势、行业分析报告：依治疗药物、疾病状况、通路和地区 - 市场预测（2025-2034）

Global Geriatric Medicines Market Size, Share, Trends, Industry Analysis Report: By Therapeutics, Condition, Distribution Channel, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，全球老年药品市场预计到2034年将达到 3,405亿美元。本研究报告对当前市场动态提供了详细的见解，并对未来市场成长进行了分析。

老年医学，也称为老年药物治疗，是指致力于开发、使用和管理专门针对老年人的药物治疗的医学专业。该领域解决与老化相关的独特的生理变化和健康挑战，包括心血管疾病、糖尿病、关节炎、神经系统疾病和呼吸系统疾病等慢性疾病。

老年医学药品市场受到全球老龄化人口不断成长以及心血管疾病、糖尿病、关节炎和神经退化性疾病等慢性病和与年龄相关的疾病患病率上升的推动。该市场的关键商业机会包括个人化医疗的进步、针对特定年龄的药物配方的开发以及新兴市场的医疗保健基础设施的扩展。

远距医疗和穿戴式装置等数位健康科技的整合等趋势改善老年人获得照护的机会和治疗依从性。预防药物和生物相似药的投资也在增加，因为它们提供了具有成本效益的解决方案。总体而言，随着全球对创新和可及治疗的需求不断上升，老年药品市场预计将稳定成长。

老年药物市场报告重点

由于老年族群糖尿病盛行率较高，抗糖尿病药物占据市场主导地位，其成长动力来自于对 GLP-1 受体促效剂等创新治疗药物的需求不断成长。

由于老年人心臟相关疾病的负担很重，心血管疾病占据了最大的市场占有率，而由于阿兹海默症和帕金森氏症的盛行率不断上升，神经系统疾病的市场占有率成长最快。

另一方面，由于送货上门的便利性和数位健康平台的日益普及，网路药局快速成长。

受先进医疗基础设施和老年人口不断成长的推动，北美占据市场主导地位。同时，由于老龄人口不断增加和医疗保健条件不断改善，亚太地区是成长最快的地区。

目录

第1章 简介

第2章 执行摘要

第3章 研究方法

第4章 全球老年药物市场洞察

  • 市场概况
  • 老年药物市场动态
    • 驱动因素和机会
      • 对与年龄相关的药物的需求不断增加
      • 为老年患者推广个人化医疗
    • 阻碍因素和挑战
      • 老年人的医疗费用高昂
  • PESTEL 分析
  • 老年医学市场的应用趋势
  • 价值链分析
  • COVID-19 影响分析

第5章 全球老年医学市场：依治疗药

  • 主要调查结果
  • 简介
  • 止痛药
  • 他汀类药物
  • 抗糖尿病药物
  • 质子帮浦抑制剂（PPI）
  • 抗凝血剂
  • 抗精神病药物
  • 其他

第6章 全球老年医学市场：依疾病状况

  • 主要调查结果
  • 简介
  • 心血管疾病
  • 神经系统疾病
  • 癌症
  • 糖尿病与代谢紊乱
  • 呼吸系统疾病
  • 其他

第7章 全球老年医学药品市场：依通路

  • 主要调查结果
  • 简介
  • 医院药房
  • 零售药局
  • 网路药局

第8章 全球老年医学药品市场：依地区

  • 主要调查结果
  • 简介
    • 老年药物市场评估，地区，2020年至2034年
  • 北美洲
    • 北美：依治疗剂分类，2020年至2034年
    • 北美：依疾病类型，2020年至2034年
    • 北美：依通路， 2020年至2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲：依治疗剂分类，2020年至2034年
    • 欧洲：依疾病类型，2020年至2034年
    • 欧洲：依通路， 2020年至2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 亚太地区：依治疗剂分类，2020年至2034年
    • 亚太地区：依疾病类型，2020年至2034年
    • 亚太地区：依通路， 2020年至2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东和非洲
    • 中东和非洲：依治疗剂分类，2020年至2034年
    • 中东和非洲：依疾病类型，2020年至2034年
    • 中东和非洲：依通路， 2020年至2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲地区
  • 拉丁美洲
    • 拉丁美洲：依治疗剂分类，2020年至2034年
    • 拉丁美洲：依疾病类型，2020年至2034年
    • 拉丁美洲：依通路， 2020年至2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲国家

第9章 竞争格局

  • 扩张与收购分析
    • 扩张
    • 收购
  • 伙伴关係/协作/协议/公开

第10章 公司简介

  • Pfizer Inc.
  • Novartis International AG
  • Sanofi
  • GlaxoSmithKline
  • Merck & Co.
  • AbbVie
  • AstraZeneca
  • Johnson & Johnson
  • Eli Lilly and Company
  • Roche
Product Code: PM1338

The global geriatric medicines market size is expected to reach USD 340.50 billion by 2034, according to a new study by Polaris Market Research. The report "Geriatric Medicines Market Size, Share, Trends, Industry Analysis Report: By Therapeutics (Analgesics, Statins, Antidiabetic, Proton Pump Inhibitors (PPIs), Anticoagulant, Antipsychotic, and Others), Condition, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Geriatric medicines, also known as geriatric pharmacotherapy, refer to a specialized branch of medicine focused on the development, use, and management of pharmaceutical treatments designed specifically for elderly individuals. This area addresses the unique physiological changes and health challenges associated with aging, including chronic conditions such as cardiovascular diseases, diabetes, arthritis, neurological disorders, and respiratory diseases.

The geriatric medicines market is driven by the growing global aging population and the rising prevalence of chronic and age-related diseases such as cardiovascular conditions, diabetes, arthritis, and neurodegenerative disorders. Key opportunities in the market include advancements in personalized medicine, the development of age-specific drug formulations, and the expansion of healthcare infrastructure in emerging markets.

Trends such as the integration of digital health technologies, including telemedicine and wearable devices, are enhancing access to care and improving treatment adherence among older adults. The market is also seeing increasing investments in preventive healthcare and biosimilars to provide cost-effective solutions. Overall, the geriatric medicines market is poised for steady growth as demand for innovative and accessible treatments continues to rise globally.

Geriatric Medicines Market Report Highlights

The antidiabetic segment dominates the market due to the high prevalence of diabetes among the elderly, with rising demand for innovative treatments such as GLP-1 receptor agonists driving growth.

Cardiovascular diseases account for the largest geriatric medicines market share, driven by the significant burden of heart-related conditions in older adults, while neurological disorders are the fastest-growing segment due to the increasing prevalence of Alzheimer's and Parkinson's diseases.

Hospital pharmacies lead the market as they are primary points of care for elderly patients with chronic diseases, whereas online pharmacies are registering the fastest growth due to the convenience of home delivery and the rising adoption of digital health platforms.

North America dominates the market, supported by advanced healthcare infrastructure and a growing elderly population, while Asia Pacific is the fastest-growing region, fueled by its expanding geriatric demographic and improving healthcare access.

Polaris Market Research has segmented the geriatric medicines market report based on therapeutics, condition, distribution channel, and region:

By Therapeutics Outlook (Revenue-USD Billion, 2020 - 2034)

  • Analgesics
  • Statins
  • Antidiabetic
  • Proton Pump Inhibitors (PPIs)
  • Anticoagulant
  • Antipsychotic
  • Others

By Condition Outlook (Revenue-USD Billion, 2020 - 2034)

  • Cardiovascular Diseases
  • Neurological Disorders
  • Cancer
  • Diabetes & Metabolic Disorders
  • Respiratory Diseases
  • Others

By Distribution Channel Outlook (Revenue-USD Billion, 2020 - 2034)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Regional Outlook (Revenue-USD Billion, 2020 - 2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Geriatric Medicines Market Insights

  • 4.1. Geriatric Medicines Market - Market Snapshot
  • 4.2. Geriatric Medicines Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Demand for Age-Specific Medications
      • 4.2.1.2. Advancements in Personalized Medicine for Elderly Patients
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Geriatric Healthcare
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Geriatric Medicines Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Geriatric Medicines Market, by Therapeutics

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • 5.3. Analgesics
    • 5.3.1. Global Geriatric Medicines Market, by Analgesics, by Region, 2020-2034 (USD Billion)
  • 5.4. Statins
    • 5.4.1. Global Geriatric Medicines Market, by Statins, by Region, 2020-2034 (USD Billion)
  • 5.5. Antidiabetic
    • 5.5.1. Global Geriatric Medicines Market, by Antidiabetic, by Region, 2020-2034 (USD Billion)
  • 5.6. Proton Pump Inhibitors (PPIs)
    • 5.6.1. Global Geriatric Medicines Market, by Proton Pump Inhibitors (PPIs), by Region, 2020-2034 (USD Billion)
  • 5.7. Anticoagulant
    • 5.7.1. Global Geriatric Medicines Market, by Anticoagulant, by Region, 2020-2034 (USD Billion)
  • 5.8. Antipsychotic
    • 5.8.1. Global Geriatric Medicines Market, by Antipsychotic, by Region, 2020-2034 (USD Billion)
  • 5.9. Others
    • 5.9.1. Global Geriatric Medicines Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Geriatric Medicines Market, by Condition

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • 6.3. Cardiovascular Diseases
    • 6.3.1. Global Geriatric Medicines Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Billion)
  • 6.4. Neurological Disorders
    • 6.4.1. Global Geriatric Medicines Market, by Neurological Disorders, by Region, 2020-2034 (USD Billion)
  • 6.5. Cancer
    • 6.5.1. Global Geriatric Medicines Market, by Cancer, by Region, 2020-2034 (USD Billion)
  • 6.6. Diabetes & Metabolic Disorders
    • 6.6.1. Global Geriatric Medicines Market, by Diabetes & Metabolic Disorders, by Region, 2020-2034 (USD Billion)
  • 6.7. Respiratory Diseases
    • 6.7.1. Global Geriatric Medicines Market, by Respiratory Diseases, by Region, 2020-2034 (USD Billion)
  • 6.8. Others
    • 6.8.1. Global Geriatric Medicines Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Geriatric Medicines Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.3. Hospital Pharmacy
    • 7.3.1. Global Geriatric Medicines Market, by Hospital Pharmacy, by Region, 2020-2034 (USD Billion)
  • 7.4. Retail Pharmacy
    • 7.4.1. Global Geriatric Medicines Market, by Retail Pharmacy, by Region, 2020-2034 (USD Billion)
  • 7.5. Online Pharmacy
    • 7.5.1. Global Geriatric Medicines Market, by Online Pharmacy, by Region, 2020-2034 (USD Billion)

8. Global Geriatric Medicines Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Geriatric Medicines Market Assessment, b y Geography, 2020-2034 (USD Billion)
  • 8.3. Geriatric Medicines Market - North America
    • 8.3.1. North America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
    • 8.3.2. North America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
    • 8.3.3. North America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.3.4. Geriatric Medicines Market - US
      • 8.3.4.1. US : Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.3.4.2. US : Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.3.4.3. U S: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.3.5. Geriatric Medicines Market - Canada
      • 8.3.5.1. Canada: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.4. Geriatric Medicines Market - Europe
    • 8.4.1. Europe: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.4. Geriatric Medicines Market - UK
      • 8.4.4.1. UK: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.5. Geriatric Medicines Market - France
      • 8.4.5.1. France: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.6. Geriatric Medicines Market - Germany
      • 8.4.6.1. Germany: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.7. Geriatric Medicines Market - Italy
      • 8.4.7.1. Italy: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.8. Geriatric Medicines Market - Spain
      • 8.4.8.1. Spain: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.9. Geriatric Medicines Market - Netherlands
      • 8.4.9.1. Netherlands: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.10. Geriatric Medicines Market - Russia
      • 8.4.10.1. Russia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.11. Geriatric Medicines Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.5. Geriatric Medicines Market - Asia Pacific
    • 8.5.1. Asia Pacific: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.4. Geriatric Medicines Market - China
      • 8.5.4.1. China: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.5. Geriatric Medicines Market - India
      • 8.5.5.1. India: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.6. Geriatric Medicines Market - Malaysia
      • 8.5.6.1. Malaysia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.7. Geriatric Medicines Market - Japan
      • 8.5.7.1. Japan: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.8. Geriatric Medicines Market - Indonesia
      • 8.5.8.1. Indonesia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.9. Geriatric Medicines Market - South Korea
      • 8.5.9.1. South Korea: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.10. Geriatric Medicines Market - Australia
      • 8.5.10.1. Australia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.11. Geriatric Medicines Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.6. Geriatric Medicines Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.4. Geriatric Medicines Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.5. Geriatric Medicines Market - UAE
      • 8.6.5.1. UAE: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.6. Geriatric Medicines Market - Israel
      • 8.6.6.1. Israel: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.7. Geriatric Medicines Market - South Africa
      • 8.6.7.1. South Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.8. Geriatric Medicines Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.7. Geriatric Medicines Market - Latin America
    • 8.7.1. Latin America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.4. Geriatric Medicines Market - Mexico
      • 8.7.4.1. Mexico: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.5. Geriatric Medicines Market - Brazil
      • 8.7.5.1. Brazil: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.6. Geriatric Medicines Market - Argentina
      • 8.7.6.1. Argentina: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.7. Geriatric Medicines Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Pfizer Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Novartis International AG
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Sanofi
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. GlaxoSmithKline
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Merck & Co.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. AbbVie
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. AstraZeneca
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Johnson & Johnson
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Eli Lilly and Company
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Roche
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables:

  • Table 1 Global Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 2 Global Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 3 Global Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 4 North America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 5 North America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 6 North America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 7 U.S.: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 8 U.S.: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 9 U.S.: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 10 Canada: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 11 Canada: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 12 Canada: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 13 Europe: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 14 Europe: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 15 Europe: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 16 UK: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 17 UK: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 18 UK: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 19 France: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 20 France: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 21 France: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 22 Germany: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 23 Germany: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 24 Germany: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 25 Italy: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 26 Italy: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 27 Italy: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 28 Spain: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 29 Spain: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 30 Spain: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 34 Russia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 35 Russia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 36 Russia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 43 China: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 44 China: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 45 China: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 46 India: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 47 India: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 48 India: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 52 Japan: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 53 Japan: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 54 Japan: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 58 South Korea: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 59 South Korea: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 60 South Korea: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 61 Australia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 62 Australia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 63 Australia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 73 UAE: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 74 UAE: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 75 UAE: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 76 Israel: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 77 Israel: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 78 Israel: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 79 South Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 80 South Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 81 South Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 85 Latin America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 86 Latin America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 87 Latin America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 88 Mexico: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 89 Mexico: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 90 Mexico: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 91 Brazil: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 92 Brazil: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 93 Brazil: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 94 Argentina: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 95 Argentina: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 96 Argentina: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Geriatric Medicines Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Therapeutics
  • Figure 7. Global Geriatric Medicines Market, by Therapeutics, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Condition
  • Figure 9. Global Geriatric Medicines Market, by Condition, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Geriatric Medicines Market, by Distribution Channel, 2024 & 2034 (USD Billion)